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l' po determine the immunogenetic characteristics of 
. atients with immune-mediated subepithelial blister-
~ dise~ses of mucous membranes, we perfonned 
all A.-tYPing for the class II MHC gene DQB1 *0301 
t ele using a direct method. Genomic DNA ex-
prated from Caucasian patients was amplified by 
r, ° Ytnerase chain reaction using primer pairs specifIC 
a
or 
the DQB loci followed by Southern blotting with 
cl pe~o"idase-conjugated sequence-specific oligonu-
",~~hde probe. Seventy-six percent (16/21) of patients 
1Il1t ocular mucosal disease (with or without oral 
aU ucosal and skin diseases) carried the DQB1 *0301 
g ele; by contrast, only 33% (14/42) of race-, age-, and 
neQography-matched normal individuals carried the 
o B1 *0301 allele (p < 0.005). The relative risk for 
s::~ar disease if DQB1 *0301 allele is present is 6.4, 
b ilar to the relative risk of8 for patients with ocular 
Ut no oral disease (pure ocular cicatricial pemphi-
---
I mmunc-mediatcd subepithelial blistering di,ea,e of mucous membranes is a heterogeneo us group of disea~es primarily affecting IllU CO US membranes with o r without somc degree of ski n invo lve ment (Chan ,'/ ti l. '1993a). T his grou p of dif!j diseases, affecting pril1Jaril y th c elderly, ha s been given 
ercl1t 11a I. ' I I ' 'd . .. I Pelll . ,n1CS: oe lllgn IIlUCOUS ll1e lll Jrane pe mp 11g01 . n catnna 
1\0 ~hlgoid, and ocular cica tri cial pcmphigoid (Ilardy rl nl . 197 1: 
div gers el fll, 1 'J77: Fille ('/ fli. 1 98~) . As a g roup of diseases with 
Crsc c l'I ' I ' f, . I . . d I the . IlIca Illanl ·csta tlo ns. t 1C t<lrgct anll gens rccoglll ze Jy 
bUll PatlCl1ts' circulating autoantibodies reHcn mch heterogeneity: 
Be~ lI ~ pemphigoid <lntigcll' (13 P230 and 13P IBO) (La bib ('/ fl i. 1986: 
120_~rd ('/ fl l , 1990; C.han 1'1 fll. 1990; 1993a: Balding C/ <II. 1996), a 
1991 Da u.n~haractenzed antigen (Sarret 1'/ fli. 1989: Chan l'/ ,Ii. 1993~' lanlll1l11_5 (Do ml oge-Hultsch l'I fli. 1992), pi 05 (Chan 1'/ al. 
), an IgA-targeted 45-kDa alltigel1 (S lIlith ('/ (/1, 1993). and 
lvlanU\ . 
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ht~~~tcvia tiO Il" OCP, ocular cicatridal pelllphigo id : UM . b.1\elllcnt rnclll -
goid, P < 0.025). In patients with oral mucosal disease 
(with or without ocular mucosal and skin diseases), 
68% (15/22) carried the DQB1 *0301 allele (p < 0.025). 
When patients with ocular disease were excluded, 
however, the increased occurrence of the DQB1 *0301 
allele in patients with oral disease was not statistically 
significant (64%, 7/11, P < 0.25). In patients with 
subepidermal blistering skin disease but no oral or 
ocular disease, there was no increase in the occur-
rence of the DQB1 *0301 allele (38%, 5/13, P > 0.5). 
The significantly increased occurrence of the 
DQB1 *0301 allele in patients with ocular mucosal 
disease may point to a distinct immunogenetic factor 
that predisposes patients to develop an ocular scar-
ring process. Key IVO/,ds: OCIlla,' cicatl-icial pemphigoidl 
poiyme,'ase clta;" react;onlSo II tltenl blot. J I'IIlest Dermatoi 
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most reccntl y. a laminin \·aria n t.' Therc is a di.rinct clinical ~ub,e[ 
of patiellt . . however, with pure ocular cicatricial pcmphgoid (pure 
OCP) . Pure OCP is characte rized clinically by scarring inAanll11U-
tion ('ontincd to conjunctival 1llLlCo,ae and illltllunopathologically 
hy a hi gh occurrcncc of ill "i, '" tibrin depmition at the ba~clllcnt 
Illembranc (UM) and by virtual ahsence of IgG class circulating 
anti-tiM antibodil's. At the m olecu lar Icyel. thcre i ' an absence in 
th c scrulll of IgG autoantibodil's against known 13M auto<lntigcm 
(Chan f'I III. 1993a) . Although pure OCI' ca n be ddincd clinically 
and illllllunopathologica ll y. its pathomechanislll remain' unclear. 
In li ght of such heterogeneou, clinical and immunologic charac-
tcri,tics in this group of patient~ with immunc-mediatcd suhepithl'-
lial hlistcring di'eascs of IIlU CO US Illl' lIIhrane, . o ur focus in thi, paper 
\\ as not to examine the indi\'idlla l target antigen. but rather to 
e:-':tlll in e the imlltunogeneti c predisposition )f thcse paticnt sub-
group' . in the hope that w e m ay , hed light on the pathomechanisms 
of the diseases dl'~ pitc the presence of <llCh heterogeneity. Pre\'iolls 
'llId ies attempted to dNeflllinc hunwn leukocytc antigen (lILA) 
a,sociat io n in this group of diseases . Initia ll y. HlA-\312 was 
reported to be associated with OCP (Mondino CI nl. I <)7<». This 
I C hall LS. MajllllldJr AA. Tr.11I 1111. 1ei.:r F. SchaullIhurg-lc\'cr G. 
hcn M. Woodle), DT. Marillkovich MP: Lal11illill-(, i, .1 1:lIllill.1 dell'll 
:tlltoanrigell ill oral pelllphigoid . .I /" ,.".</ /),., ",,1/,,/ 11l6:R 11. 199(> (ah'lr) . 
on22-202X/ I)71 1(1 .50 ' opyright c' 191)7 by T Ill' ocicl), for In\'C,tigati"c J)ermalolo~y. Inc. 
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association was not confirmed by a later study, and HLA-DR4, 
DRS, DQw3. B8, B35, and B49 were reported to bc associated 
with OCP (Zaltas ct al. J 989) . Restriction fragmcnt length poly-
morphism analyses subtyped DQw3 to be the DQw7 
(DQB 1 *03( 1) allele. and the DQB 1 *()30 1 allele was associated 
with mucous membrane pemphigoid of ora l and ocular mucosae 
(Ahmed ef al. 1991 ; Yunis ef al. 1994) . In all of the previous studies, 
however, the patients' clinical ch aracteristics werc n ot compre he n-
sively ddincd in disti nguishing those with ora l. ocular , and skin 
manifestations (Mondino el Ill, 1979; Zaltas el Ill, 1989; Ahm cd ci ai, 
1991; Yunis el ai, 1994) . Definit ion of clini cal features is criti ca l in 
defin ing subtypes of pemphigoid. For in st'l11ce. patients with a uto-
antibodies against BM componcnts, bullous pcmph igoid anti gens, 
laminin-5 , and p10S, a ll cxhibi ted ski n or oral les ions, in conjunc-
tion with (o r without) ocu lar scarring (Ch an el ai , 1993a; 1993 b; 
Dom loge-Hu ltsch el ai, 1992). Furth ermorc, n orm al controls 
should be age-, race-, and geography-m atch cd to hclp account for 
apparent discquilibrium due to ethnic enrichments in elderly re-
gional referral populations not rep resen ted in the sam e propo rtion 
in a bone marrow transp lantation bank (Yunis e ( ai, 1994). The 
purpose of this stu d y, therefore, was to use a direct HLA typing 
method to determine the HLA DQB1 *0301 association with a 
group of patients affected with iml11un e-mediated subepithe lial 
mucou s membrane blistering diseases classificd according to clini-
ca l. immunopathologic, and molecular ch aracterization (Chan e/ nl., 
1993a). Our ana lyses were restricted to the HLA-DQB 1 *0301 
allele because previous studies revealed this allcle to be most Iikc ly 
associated with OCP (Ahmed e( ai, 1991). 
MATERIALS AND METHODS 
Patient Selection Included in this study were unrelated Ca llcasian 
patients fi·olll the midwestern United Statcs (Michigan and Ill inois). All 
paticnts had clinical features of skin and/or mu cosal blistering diseases 
characteristic for immune-Illediated subepithelial blistering diseases (Chan el 
nl. 1993:.) alld were documented by the presellce of linear band of EM 
imn1Une deposits with direct immunoAuorescencc studies 011 perilcsional or 
nonlesiolla l biopsie, (Chan cl nl, 1993a) . III biopsies obt"ined frolll patienrs 
with OCp. the percent of BM il1llllunoreactants detectcd arc: IgG (63%), 
IgA (32')1,.). IgM (42%). C3 (6.3')1,, ). and tibrin (47')1,.). Histopathologic 
exam ination connnlHod thc subepithelial bliste ring process in all patients 
with sk ill or oral mucosa l lesions but was not performed in all pure OCP 
patients due to the potential ri,k of inducing severe scarri.ng process and the 
lack of ,pecific Endings (HeiUgenha us pI nl. 1993; Chan el nl. 1991, 1993,,). 
Patients were excluded from this study if the ir diagnoses fulfill ed the 
clinica l. histopathologic. and imm unologic criteria for the fo llowing dis-
ca,,,s: herpes gestation is (pemphigoid gestationis). linea r IgA bullous der-
matosis. chronic bullous dermatosis of childhood. epidermolysis bullosa 
acquisita. Brunsting-Perry ciC<ltricial pemphigoid, and li chen pl<lnus (Brun-
sting and Perry 1957; Woodley (' I ai, 1984; Din cf nl. 1990; Zone e( nl. 
1990). Nornlal contro ls '''e re age-Inatchcd unrelated Caucas ian vo lun teers 
frOl11 the midwestern United States (Michigan and Illinois) who had no 
history of blistering disease of skin or mucosae. The patients were sub-
grol.ped according to thei r clini ca l ma nifestations (Chan el nl. 1993a). 
lJ1direct unmllnofiuorescence Indirect immunoAuorescence studies of 
circu lating IgG anti-BM autoantibodies on I M NaCI-sp lit nonnal human 
,kin substrate (Gammon el ai, 1(84) was pel·formed on se rum collected frolll 
89% (40/ 45) patient, during active di sease states. Six-micrOllleter thick 
cryosections of salt-split skin were in cubated with the patients' serum 
di luted to 1:3 ,md I : I 0, tallowed b)" incubation with fluorescein-conjugated 
goat anti-human IgG (Kallcstad Diagnostics. Austin, TX). Serum fi·o m 
patients with typical epidennoJysis bullo," aCCJuisita and bullous pemphigoid 
311 d scrUI11 froln 110fl11al individuals were included as po'i iti vc and negative 
controls. 
Polyrner<lse C hain Amplification of the HLA-DQB Loci Gcnom ic 
DNA was extracted either directly from peripheral blood leukocytes or 
f)·om Ep,te in Barr vi rus-immortal ized n ce ll s (Tosato c/ nl, 1985) using a 
cOll1merciall y ""<lilahle DNA extraction kit (Stratagem" La.1olla , CAl. After 
th" concentrations were measLired by spectrophotoll1eter at 260 and 280 11m 
wave lengths, the DNA samples were used as template to amplify the 
HLA-DQU loci with published primer pairs by polymerase chain reactioll 
(peR.). using" Coy thennocycler (Coy. Grass Lake. MI) (Bug"wan and 
Erlich . 19!J I) . BrieAy. an 100-fl.1 PCR reaction mixture contains the fina l 
conccntratiom of the fo llowing: 20 mM Tris- HC I (pH 8.4); 50 lllM KCI; I 
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mM dithiothreitol; 2 fl.g of genomic DNA template; 2 mM MgCI 2 ; 100n~~ 
each of dATP. dTTp. dCTP. and GTP: 2S0 fl.M each of the fonv"rd ( 
reverse primers; 3 U of Tnq DNA polymerase (perkin-Ell1ler Corp ., FOI; 
City. CAl. After prcheatiJlg the PCR tubes to 94 °C for 4 min. the 35 c)'c ~ 
PC R. program was perfomlcd either at 94"C . I min; 55°C. 1 min ; 72' C: ' 
min with pri mer set I (forwa rd S'-CATGTGCTACTTCACCAACCG-!; 
reverse 5'-CTGGTAGTTGTGTCTGCACAC-3'; specifi c for DQBI ar; 
DQB2 loci, 11th HlA Workshop) or at 94 °C. I min 40 s; 6l1°C, I ,nu' ~~. 
primer set 2 (forward 5'-AGGGATCCCCGCAGAGGATTTCGTGTA ri6t 
3': reverse 5'-TCCTGCAGGGCGACGACGCTCACCTCCCC-3'; spc .~ 
for DQB 1 locus onl y) (Bugawan and Erli ch . 1991). T he ampli fi cal~t! 
cfficiency was examined by ethidiu1l1 bromide staining of the a,npb~ 
DNA sepa rated by .I.S'% agarose ge l electropho~esis . fn cases w here no PUIi" 
product was vlsuahzcd from the pnmary ampli ficatIOn. secondary alllP I'll 
cation was performed using S fl.1 of the primary PCR. product ;1S J) . 
template. 
1*0301 Southern Blot and Dot-Blot Analyses of tbe HLA-DQB d ~ 
Allele T he PCR prod u ct~, confirmed by agarosc gels. were transferrc h'< 
ny l o~l membranes (Nytran plus , Schleicher & SchucH. Kccne. NH). el~hI 
by direct dot-blott1l1g O J' by South ern blott1l1g. and UV- cross-hnkcd . . oJ! 
presence of the HLA-DQB 1 · 030 I allele was exam ined by h ybridI2a~_ . 
with a peroxidase-conjugated sequence-speciti c o ligonucleotide probe ~ 
ACGTGGAGGTGTACCGG-3') (Synthetic Genetics. San Diego. Ci\J art 
Southern-blo tted PCR-amplifi ed DNA sa mples (by primer set "I) an .",,' 
dot-blotted samples (by primer set 2). Pre-hybridization and hybridlZa~ oJ 
(2 pmol probe per ml) were performed according to an esta blished rnC{.l/ 
(Bugawan and Erlich. 1991). Contro ls include one negative (9020) 3n1 ~Ol 
positive (9016 and 9(70) homozygous ce ll lines for the HLA-DQ B 1.0 o. 
allele obtained from American Society for Histocompatibi lity and Illlnl 
nogenetics (Boston, MA). 
tiiY 
Statistical Analyses Two-sided chi-sq uared (x' ) tcst for 2 X2 c~" i~ 
gcncy tables (one degree offrecdom) was carried out with Yate' s contU~tb; 
correction (Ki rkwood. 1988). The analyses compared the occurrence 0 b. 
DQB 1*0301 allele of each patient group with that of normal CO:l~: r 
Probability (1') va lues were obta ll1 cd fi'ol11 the X' dlStrlbutlon table . \ /1 
va lue of less than O.OS was considercd to be statistica lly sign ificant. JU lal:r, 




DQB1 *0301 All I I· . . I ·fi byb fl e e To e IITIma te potentIa nonspeCl IC rl 
iZatioll with d o t-bl ot an alysis, all ampl.ified DNA samples \V~( 
subjected to Sou the rn blot anal yses, which reveals size-spec hi 
h ybridization . Table I exhibits the percellt occurre nce of ;aC 
DQBl *0301 alle le in different paticnt subgroups. It is apparent t,\e 
I · r . I - I 1 dlse"· t 1e I11crease o · percent II1V O vem ent of OCll ar mucosa I " 
parallels the in creased occu rre nce of the DQll1 *0301 allele. SLlC\1 
trend was n ot obser ved for onil mu cosal disease. To detenll~:tf 
whether the association of DQBl ' 0301 allele is specifi c for ocu 'II 
1 d · . I · ucsoo mucosa Isease, we regJ·ouped the patlents [Q answer t l.I S q OCP 
(Table II). Eigh ty per cent (81 I 0) of paticnts with pure UI 
(ocular but 110 oral or ski n diseases) had the DQB1 ' 030 1 allclciS). 
contrast to on ly 33'1., (14/42) of the norn~a l volunteers (p < 0·°760/. 
If all patIents WIth ocula r mucosal dIsease are mclude~ , esl 
(16/21) of pa tients (with or without oral mucosal o r ski n dlSCaS ral 
had the DQB1 *0301 allele (p < 0.O(5). If a ll patients with nO 01 
mucosal disease arc included, 68% ( 15122) of patients (Wit llle 
witho ut ocular mucosa l or sk in di seases) had the DQBl *0301 a, :(. 
(p < 0.025). For patients with oral but n o ocular disease, ho \~ev 01 
the in crease in the DQB1 *03 01 allele (64%, 7/11) waS t1" e 
statisticall y significant (p < 0.25). Small sample size m ay h~UI 
accounted for this. O nl y 38(X, (5/13) patients with skin diseaSe
oj). 
no oral o r ocular disease h ad the DQB1 *030J allele (p /' J se 
WI I f d ·tb t 10 1en resu ts 0 Southern blot analyses were compare W l r-JA 
of d.ot-blot analyses p e rform e d with amplified geno mIC Vrllf obta~ned from 31 patients, identical results w ere o bta in ed. d.e 
re la t Ive ri sk of ocular disease (excluding o ral disease) If tile 
DQB1 *(1301 all ele is present is 8.0, substantially hi g her thMI 5). 
nsk o f oral disease (excluding ocula r disease) (relative ri sk == 3· 
Correlation ofDQB1*0301 Allele with Circulating A-nti-V~~ 
A ~ utoantibodies As the percent invo lve m c nt of ocu lar rn tl lIel1 
dlse<lse and the percent occurrence of thc DQB1 *030 1 ~ 
VOL. 10H. NO. 2 FEllRU AR Y 1997 HLA- I)QBI ' I13111 IN OCULAR PEMPH IGOID 131 
Table I. 
----
Clinical and Allelic Data of Selected Subgroups of Immune-Mediated Subepithelial Blistering Diseases of Skin 





































No . and H~, ()cclIrn.' Il Cc" 
DQ131 *()301 Allele 
14 (3.1%) 
S (3WV., ) 
S (~Il%) 








~ Ncrcent of p ;llicl1r~ w ith di,casc ill \'u l v il1~ skin. u r;!! I1Il1 CO\;JL' , o r oClIbr 11lll co~al!. 
r CI~I:lill~cr .'lIlel pc rrc nr of ,,:ltic llI'S I~ ad Ih e, DQB I *(1.'\0 ', :llh.~.k· determilled hr Sll ufh l'rn hl ()~ ... futiie ... 
" T . c.11 s llbg rO Il I'~ :U:COl"d lll g: to dl"ca'ic 1J1\' O l n .' IIIl' 1I1 111 ,klll. ()r~t1. a lld ocular IlI1l C(l'<lC (ell,," ('( 1,/ , 1')93a) . 
, A Ot;] ] Illll1lbcr of piltknr c; in cotc h group . 
I p ge at Onset nr the d isease (age al the til1le of hlond coll cclioll Ii..., r Ilormals) . 
' E~ rcc l1l OC('urrl'llo .. ' or c irc ubtillg' IgG :ll1li- BM :Jlllibodic\ (in rho"I,:' rc c; ccd. S9'Y..,) hy indircCl illl Ill1l1l 0 f-iU OI"l'!IoCCI1Cl' ;; Iudil'\ 011 o;;:d l-;;plit ,kin l- llh"II·,!tc,. ND. I10t dnill' . 
even patien ts had l.'1a:i .. ic~11 hull ou:i p CllIphignio ; two padelll " hao Ullcl:1'i\ifit.:'o di'l'a~l.' \\ ilh :llIt o:1Illihodil'~ ng;1in .. t n lo wer lalllin;l hH' idn componc nt. 
;ncreased, the per cent occurrence of circulating anti-BM antibod-
~~ .. 
ali I creased (Table I) . Whell the occurren cc of DQB I "' 030 I 
aUc e ~va s compared with that of circula tin g anti-BM antibodies in 
(g PatJ.ents with immune-mediated subepith elial blistCl"ing di seases 
re~oups 1-4 in Table I), w e contirmed that there was no linking 
de atto ll ship between the occurrence of DQB I *030 I a lle le and 
10 teCtable c ircu latin g anri-BM antibodies, because there was a 
in werpercenr of de t~ctab l e circul atin g ami-BM antibod ies present 
th patients who had the DQB I ' 030 I allele (58'!!' •. 15/26) than in 
Ose who did no t (71 %, 10/ 14). 
DiSCUSSION 
~;P is generall y considered to be an iml11ulle-mediated blistcling 
sal e~se Invo lving the ocular m ucosa. Autoimlllunity aga in st muco-
hu 1\1 compon ents is a possible etiology. A co mll1OI1 feature of 
Inan aut . .. I . . f . I I (y 'Olll1l11unlty IS t lC actIvatIOn 0 autoreactlve ylllp l ocytes 
Catilla c tCe , n el aI, 1992). Although gcnes that encode lOr T-ce ll 
Co epto:s, peptide generati o n. transport prote in, and major hi sto-
in I11pattbility complex (MH C ) m olecules arc potential ca ndidates 
latlnfluencing the activarion of auto reactive lymph ocytes, o nl y the 
ter set (M lVith H C m olecules) has a c1carly esta blished assoclabo n 
rac hUl11an disease (Yeatman el aI, 1992; T hcofilopoul os 1995). In 
luri, the bindin g of 3n aut03nti gcn h y an MHC m o lecul c o n the 
anti aCe of the antigen-prescnting cell is a prerequisite for effective 
be gcn prescn tati o n and T-cell iml11unl' respon sivencss (Kroncn-
C(lrg, 1 ~9 1 ). Expcl'imenta Il y indu ced chan g l: s in MHC genes by thc 
I1 gell1 . 
efFe c, transgcnlc , o r ge ne-knocko ut IIl ctho d ha s had profound 
e.xp~ts On the dcvelopm cnt of autoiml11une diseases in val'ious 
the Crtnlcntal and spontaneous animal 1110 d els, stron gly supporting 
hYb ro~e of these genes (Thcotilopoulos 1995). HLA typing by 
pc~~IZati~n with scq~lCn cc-spcc iti c o li gonu cleotidc .probes o n 
inr, alllplified DNA IS the o nl y lIlethod that pmvldcs direct 
(~rlll ation about thc scque nce variati o n in indi vidual allele 
ordsWorth el al. 1990). T he current stud y \Vas performcd 
'table I ltsk ,I. Occurrence of DQB1 *0301 Allele and Relative 
s 111 Patients Subgrouped by Distribution of Muscosal 
'------ Diseases" 
SWb ~ N DQUI*030 1 Allel e Signit-"i c:lncl: v .... Nannal 
Relative I~isk 
(9S'X, e l) 
Norll1al ----------
Or- / o 42 33'X, NA NA 
AU Or ,..c - 1.1 3ll% P '> 0 .5 1.2 (NC) 
0'+/0 22 6ll% P < 0.025 4..1 (1.3-14 .2) 
AII O
c
:- II (,·1% 1' < 11.25 3 .5(0.7- 18 .3) 
Or- f O 2 1 76%1 p ...... n.oos 6. -1 ( 1.9-22.n) 
~ 10 80% p < O.02S H.I) (1.4-46 . 1) 
. ~~ . 
InVOlVed. I.Hums: ()c. ocuinr 1l1L1 l'O:';H.' : Or, or:11 1111 H.: ()~ :1e ; N;\. 1l t) I1 ;Jpphc~lhl e; -f . 
e~tt~111 I' - , nOI illvol ved: C I. cOlltidcnn.' illl l.'rva l: NC. IHH ca klll ~lhlc du e to .1Il 
e Y '\ 111 <1 11 x. 
preciscl)' for such dil'cct informatio n . The ~ignifi canr increase of 
occurrc nce of DQB I "' 030 I allele in p 'ltients with pure ocr (80%) 
and ill all pati ents with ocul ar disease (with o r without oral o r skin 
diseases) (76'1.,), ,Jlon g with the reccn t docLllllentation of HLA-
DQB I codon 57's cl'itical role in peptide bindin g and recognition, 
underlines the sign iti ca nce of our fi ndings (Kowk 1'1 al. 1996) . The 
absence of assoc iation of the DQBl *()301 allele with patients who 
have skin discase but no ora l or ocular 111ucos,]1 dis~ase further 
co nfirms that this allcle is specitica lly lin kcd to Illucosa l diseasc, 
espccia lly ocular mucosal discasc. T hu s. our fI ndings con firmed this 
all~lc'~ association with OC t> previoLl sly reported by others 
(Ahmed CI nl, 199 1) but did not co nclusively confi rm the associa-
tion of this ,JlIeIe with ora l pel11phigoid (Yunis ('f aI , 1994), probabl y 
du e to sl11 a ll sa mple sizl'. 
We pr~vioLlsl y reported four paticnts w ho developed ocr as a 
seq ue la of ocula r epi the li al injuries dUI'ing cpisodes of Stcve lls-
) o hn 50ns syndrol11c (Chan 1'1 "I, 1991). and wc hypothesized th at 
seve re epi the lia l injuries m igh t rcsult in autoim1l1unization of these 
paticnts with epidcrl11al antigens not norma ll y pr~sented to the 
ill1l11une systc l11. lead in g to OCP. Studies of the class I HLA 
antigens in C aucasian patients wh o had ocular involvelllent in 
Stcve ns-Johnsons syndrome revealed that HLA-Bw44 was signifi-
ca ntl y increased (M o ndin o 1'1 aI, 1982). Direct DNA analysis of c lass 
II HLA antigens also revealed a sign itica nt increase in th e HLA-
DQ 131 "030 I a ll e le in Ca ucasian patients affected w ith erythema 
Illultifo rme (Khalil el nl, 199 1) . U nfo rtunate ly, the specific data tor 
th e trequcncy of DQB I ' 030 I a llel e in paticnts with c l)'thcma 
l11ulti fo rmc m aj or (Stevens-Johnson synd rome) and ocula r involve-
l11e nt was not provided (Kh alil £'1 III, 199 1) . 
OC P is general ly considered to bc an autoil11mune disease 
in volving the hUl110ral iml11un e system. Although ill "i"" bound 
immune dcposits werc genera ll y demonstra ted ill perilesional or 
n o nl cs iona l biopsy speci1l1ens. nonspecific immulle deposits, such as 
tibrin. are detec ted in som e paticnts rather than im1l1unoglobulins. 
the cffec tor of thc hUllloral immune system (Lcona rd £'1 nl. 1988; 
C han 1'1 nl, 1993a). In addition, ci rculatin g anti-BM antibodies in 
OCP patie nts are o nly rarely detected (l3ernard £'1 nl . 1990; C h an ('I 
nl, 1993<1) (Table I) . When spec ifi c antigens were dClllonstrated to 
bc targets of patien ts' au toantibo dics. thesc paticnts usuall y had 
cu taneous blistc rs (Bern ard 1'1 ,1/, 1990; C h an ('/ "I, 1990; C han cl nl, 
1993:1; Balding £'1 al. 1 996). raising thc questio n w hethe r thcse 
ta rget anti gens are l11u cosa-specitic or si mpl y skin antige ns targe ted 
by the autoantibodies . T h us. th c role of <lnti-BM autoantibodics in 
thc pathomechani sms of t lte chronic c ica tri z in g inflammatory pro-
cess in DCP remains un clear. and the ro lcs of other bnlllchcs of 
iml11un e syste m sho uld bc consi dercd . Cell-mediatcd immunity, 
rath e r th an antibody-mediated im11lunity, m ay be a critical dcre r-
minan t of the ch ro nj c inflam1l1atory <ca rrin g proccss of ocul ar 
surfaccs aftcr aCllte inriating eve nts such as injury b y autoantibod y 
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targeting th e mucosal 8M or injury by inflammatory processes su ch 
as the Ste vens-johllsons syndromc (Ch an et ai , 1991; 1993a) . 
Alth o ugh the detailed immuno pathogeni c m echanism s in o c r 
remain to be further investigated, the fll1ding o f significantly 
increased occ urrence of the DQB1 *0301 allele in pati ents with 
ocular mucosal disease indicates a distinct immunogenetic fa ctor 
that predisposes patients to devclop an ocular scarring process and 
points to a future direc tion for cica tricial pemplligoid research. 
T his 1I10rk is sIIppOl1ed ill }Jal1 (1)1 n YOIIJJg IJJl les 'i.~ a10r A ward ('0 L. S, ClwlJ) )i'OlJJ 
rllr N"rrl'lJIesrem Memorial FO IIJJda,i"" (Clricn.~CI, IL), I f!e I/Io llid like rrr r/,allk 
Xlle-So ll,~ IVollg, T im ~Va"g, andJII" f'I'/I,~fO I' Ihl'il' rer/I/riral assislall [(" 
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